-
Serum drug concentrations to optimize switching from adalimumab to etanercept in rheumatoid arthritis
l’ Ami, M. J., Ruwaard, J., Krieckaert, C. L. M., Nurmohamed, M. T., van Vollenhoven, R. F., Rispens, T. & Wolbink, G. J., 4 Jul 2019, In: Scandinavian journal of rheumatology. 48, 4, p. 266-270 5 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay
Berkhout, L. C., l'Ami, M. J., Ruwaard, J., Hart, M. H., Ooijevaar-de Heer, P., Bloem, K., Nurmohamed, M. T., van Vollenhoven, R. F., Boers, M., Alvarez, D. F., Smith, C. H., Wolbink, G. J. & Rispens, T., 30 Jan 2019, In: Science translational medicine. 11, 477, aat3356.Research output: Contribution to journal › Article* › Academic › peer-review
-
Differences in palmoplantar pustulosis and psoriasis vulgaris in patients with rheumatoid arthritis or ankylosing spondylitis treated with biological therapy
Ruwaard, J., van der Vlugt, E. R. & Wolbink, G., 1 Jan 2019, In: Journal of rheumatology. 46, 1, p. 117-118 2 p.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
- All publications
